In very large prostates, robot offers significant advantages
By Jaya Sai Chavali, MD; Juan Garisto, MD; and Jihad Kaouk, MD
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
In this video case study, we demonstrate our step-by-step simplified robot-assisted prostatectomy technique to successfully treat benign prostatic hyperplasia (BPH). Of particular note, the robotic approach offers excellent visualization of the surgical field, decreases blood loss and most important, speeds healing, even in cases like this one with a large (100+ cc) prostate. Rapid healing is due to our added ability to advance the mucosa over the excision site to eliminate raw surface at the excision bed.
A 73-year-old man with a history of lower urinary tract symptoms presented to our practice with an International Prostate Symptom Score (IPSS) of 22 and urinary retention. Preoperative assessment included a cystoscopy that demonstrated a bilobar obstructing prostate (estimated prostate volume of 400cc) and normal urothelial lining. His PSA was 2.2. Due to failed medical therapy and the severity of the gentleman’s complaints, we elected to perform robot-assisted simple prostatectomy.
We have refined a simplified robot-assisted prostatectomy technique that provides excellent visualization. Major steps in this robotic procedure:
Advertisement
Total operative time was 186 minutes with an estimated blood loss of 200 ml. Pathology reported BPH with a prostate volume of ±300 cc. There were no intraoperative complications.
The patient was discharged on postoperative day one. A cystogram performed two weeks after surgery showed a dye-filling defect contained in the prostatic capsule area and no extravasation. The vesicourethral junction was intact after the removal of the adenoma.
Our simplified robot-assisted prostatectomy procedure, simple to perform by experienced surgeons, offers distinct advantages particularly for patients with large prostate volumes.
Drs. Chavali and Garisto are clinical fellows at the Glickman Urological & Kidney Institute.
Advertisement
Advertisement
Reproductive urologists publish a contemporary review to guide practice
Two recent cases show favorable pain and cosmesis outcomes
Meta-analysis assesses outcomes in adolescent age vs. mid-adulthood
Proteinuria reduction remains the most important treatment target.
IgA nephropathy is a relatively common autoimmune glomerular disease that can be diagnosed only by biopsy
Oncologic and functional outcomes are promising, but selection is key
Cleveland Clinic is first to use the device, known formerly as the UroMonitor
First single-port renal vein transposition reduces recovery time and improves outcomes